| Contents |
The generation of evidence in medicine : evaluating the benefits and harms of treatment -- The use of evidence : federal regulation of prescription drugs and medical devices -- The subversion of evidence : the Rosiglitazone story -- Operate first, evidence later : the special case of surgery -- Doctors and evidence : evidence-based medicine -- Comparative effective research : a new "silver bullet" for U.S. health care costs -- The legislative odyssey of comparative effectiveness research : birth in 2002 to the first federal mandate in 2003 -- 2005 to 2007 : the health services research community stirs, the "B" word awakens policymakers, and the House CHAMP Act creates divisions -- 2008 to 2010 : the Baucus-Conrad bills, the American Recovery and Reinvestment Act, and the Patient Protection and Affordable Care Act -- The scope, financing, and processes of federally-mandated comparative effectiveness research and why they matter -- Aligning clinical practice with best evidence of comparative effectiveness : payment policy for evidence-based medical care -- Dealing with uncertainty : payment policy for the generation of evidence as part of clinical practice. |
